Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Date of authorisation: 26/08/2010, Revision: 22, Status: Authorised

Submitted by Anonymous (not verified) on 25 August 2026 - 9:52

Human medicines European public assessment report (EPAR): Vpriv, velaglucerase alfa, Date of authorisation: 26/08/2010, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau), chenodeoxycholic acid, Date of authorisation: 10/04/2017, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 24 August 2026 - 16:40

Human medicines European public assessment report (EPAR): Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau), chenodeoxycholic acid, Date of authorisation: 10/04/2017, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 24 August 2026 - 16:22

Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 3, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More